← Leaderboards
Hartzell V. Schaff
Mayo Clinic Rochester
$1,056,597
Attributed
$3,169,790
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–15$2M$1.5M$1M$500K$0
'13
'14
'15
Funding mix
By agency
NIH$3,169,790 · 2
By mechanism
UH3$2,018,643 · 1
UH2$1,151,147 · 1
Top collaborators
- Maurice Enriquez-Sarano5 shared
- Jordan D Miller5 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Horng H Chen$12,297,202
- Alexander Egbe$8,108,397
- Elizabeth C. Lorenz$795,300
- Cynthia H McCollough$18,009,183
- Daniel J. Tschumperlin$19,462,790
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAnimal ModelAntioxidantsAortic ValveAortic Valve DisorderAortic Valve ReplacementAortic Valve StenosisApolipoproteinsAreaAttenuatedBiological MarkersBiological ProcessBloodBody SystemBone DensityCalcificationCalcifiedCalciumCardiovascular SystemCellsChronicCofactorCross-Over StudiesCytokine
Grant awards (5)
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$969,945
UH3 · FY2015 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$681,374
UH3 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$367,324
UH3 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$163,310
UH2 · FY2014 · TR
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$987,837
UH2 · FY2013 · TR